We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
BAFF-R/BR3 (C-Terminus) antibody
Tumor necrosis factor receptor superfamily member 13C
B-cell-activating factor receptor
BAFF receptor, BAFF-R
BLyS receptor 3
prolixin
CD_antigen: CD268
Gene name: TNFRSF13C, BAFFR, BR3, BROMIX, CVID4
B-cell-activating factor receptor
BAFF receptor, BAFF-R
BLyS receptor 3
prolixin
CD_antigen: CD268
Gene name: TNFRSF13C, BAFFR, BR3, BROMIX, CVID4
As low as
€671.00
In stock
Ref
00097746
BAFF-R/BR3 is the third receptor identified for BAFF. It is specific for BAFF and plays a major role in BAFF-induced B cell development and survival. BAFF and its receptors are involved in B cell associated autoimmune diseases and activate NF-κB and c-jun N-terminal kinase.
ID Covalab | pab60040 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | Synthetic peptide corresponding to aa 169-183 at the C-terminus of human BAFF-R. |
Activity cross reaction | Reacts with human, mouse and rat BAFF-R/BR3. |
Species | Hu, Ms, Rat |
Labelling | None |
Form | Purified |
Preservative | NaN3 0.02% |
Storage instructions | Stable for at least one year at +4 or -20°C. Avoid multiple freeze-thaw cycles. |
Target | BAFF-R/BR3 |
Uniprot ID | Q96RJ3 |
Gene ID | 115650 |
Applications | IHC, WB |
Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only: WB (2 - 5 µg/ml) IHC (5 µg/ml) |
Write Your Own Review